HeartSciences (HSCSW) Net Margin (2021 - 2025)

HeartSciences (HSCSW) has reported Net Margin for 5 consecutive years, with 97269.0% the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Margin changed N/A year-over-year to 97269.0%; the trailing twelve-month figure through Apr 2026 stood at 107010.15% (down 6053758.0% YoY), and the FY2026 full-year result was 212222.92%, down 870513.0% from the prior year.
• Net Margin advanced to 97269.0% in Q4 2025 per HSCSW's latest filing, from 108305.63% in the prior quarter.
• Across five years, Net Margin topped out at 10048.78% in Q3 2021 and bottomed at 108305.63% in Q3 2025.
• Historically, Net Margin has averaged 53270.32% across 5 years, with a median of 48741.44% in 2022.
• The sharpest annual moves came in 2022 and 2024: Net Margin slumped 3912947 bps in 2022, then soared 5764355 bps in 2024.
• Over 5 years, Net Margin stood at 10048.78% in 2021, then tumbled by 389 bps to 49178.25% in 2022, then gained by 9 bps to 44830.28% in 2023, then jumped by 75 bps to 11182.5% in 2024, then plunged by 770 bps to 97269.0% in 2025.
• According to Business Quant data, Net Margin over the past three periods registered 97269.0%, 108305.63%, and 48304.62% for Q4 2025, Q3 2025, and Q2 2025 respectively.